Navigation Links
ImpactRx Closes Series E Round of Financing
Date:1/11/2010

MT. LAUREL, N.J., Jan. 11 /PRNewswire/ -- ImpactRx® announced today that the company has executed a Series E round of financing in the amount of $1.2 million, of which the first tranche of $678,040 was closed on December 23, 2009. ImpactRx is the pioneering force in measuring the impact of pharmaceutical promotion on the prescribing behavior of the nation's highest value physicians.

"In a year where venture capital investing all but dried up it is rewarding that we could raise investment dollars from our existing investors," said Richard Altus, CEO and President. "The sustained support of ImpactRx by its longstanding investors is a clear acknowledgement of the success achieved by the company over its nine-year history," Altus continued. "To secure this investment in a year like 2009, when the industry faced the challenges of the global recession coupled with the headwinds facing all service providers within the pharmaceutical marketplace, is a vote of confidence in our future," said Altus.

ImpactRx also reported that in 2009 the company's revenues were $28,952,000 which in turn generated free cash flow of $2.2 million prior to any investment activity as compared to free cash of $1.4 million in 2008, representing a 57% increase. In commenting on this achievement, CEO Altus said, "our ability to internally generate incremental cash flow under the very difficult market conditions that existed in 2009 is a real sign of the strength of our business." "The additional funding, coupled with the internally generated free cash flow, will help us expedite our product development and infrastructure improvement plans as well as upgrade our modeling capabilities," continued Altus. "We are investing to accelerate our ability to deliver even more value to our clients," Altus further stated.

"Ending 2009 with a strong balance sheet and no debt, ImpactRx is positioned for high growth and expansion in 2010," Altus
'/>"/>

SOURCE ImpactRx
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. comScore Announces Availability of comScore/ImpactRx Physician Behavioral Measurement(TM) Solution
2. ImpactRx Announces Expansion and Addition of Physician Information Networks
3. Senator Landrieu Closes Office: Constituents Turned Away at the Door, Callers Reach Only Busy Signals
4. CapitalSource Closes First Step of Long-Term Care Facility Sale to Omega Healthcare Investors
5. Hard to Treat Diseases (HTDS) Closes 1 Million Dollar Contract Indian Pharmaceutical
6. Registration Closes Soon for FDAs Second Annual Science Writers Symposium
7. Augmenix, Inc. Closes $6.1 Million Financing
8. Beckman Coulter Announces Third Quarter 2009 Earnings to be Released on Thursday, October 29, 2009, After Market Closes
9. Archi-Tech Closes the Gap Between Pharmaceutical Managed Care and Primary Sales with Pull-Through Reporting Capabilities
10. Greenway Medical Technologies Closes 11th Consecutive Fiscal Year of Positive Growth
11. AdvanDx Closes $8 Million Financing Round and Elects New Board Member
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2014)... 21, 2014 “Cluster headaches are sometimes ... and difficult to resolve,” said Steve Young of Ew ... of a pain that is more intense.” , “It ... cluster headaches, or migraines, that medical research is pointing ... system,” he added. , Serotonin (5-HT, 5-hydroxytryptamine) is a ...
(Date:9/21/2014)... California (PRWEB) September 21, 2014 According to ... experienced the highest birth rate since 1966 (10.5 births per ... in their early 40s has risen steadily by 2 percent ... includes births to women aged 50 and over) also rose, ... that there were more than nine times as many first ...
(Date:9/20/2014)... 2014 Weight Destroyer , a ... expert Michael Wren that has already helped tens of ... health conditions like high blood pressure, high cholesterol, and ... prompting an investigative review. , “Weight Destroyer is ... down by showing people what is truly effective when ...
(Date:9/20/2014)... (PRWEB) September 21, 2014 Increases ... contributing to greater waste treatment volumes. However, government ... diverting waste from landfill. According to IBISWorld industry ... have implemented strategies aimed at reducing the volume ... waste recycled and recovered.” Still, a large proportion ...
(Date:9/20/2014)... The print component of “Work-Life ... the Calgary Herald, with a circulation of approximately ... The digital component is distributed nationally through a ... of top news sites and partner outlets. To ... http://www.worklifebalanceinfo.ca . , The publication features an ...
Breaking Medicine News(10 mins):Health News:Homeostasis: Equinox Serotonin (5HT) Headache Stories ~ New on the Bryan William Brickner Blog 2Health News:Statistics Reveal That the Number of 'Older' First-Time Mothers Is Growing 2Health News:Statistics Reveal That the Number of 'Older' First-Time Mothers Is Growing 3Health News:Statistics Reveal That the Number of 'Older' First-Time Mothers Is Growing 4Health News:Weight Destroyer: Review Exposes Michael Wren’s Guide to Effective Weight Loss and Improved Health 2Health News:Weight Destroyer: Review Exposes Michael Wren’s Guide to Effective Weight Loss and Improved Health 3Health News:Waste Treatment and Disposal Services in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Waste Treatment and Disposal Services in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Getting ‘Wellthy’: Mediaplanet’s “Work-Life Wellness” campaign puts stock in the personal and economic gains of healthy, vital workplace environments for Canadians 2
... United American,Healthcare Corporation has nominated Bruce R. Galloway for ... Meeting of Shareholders scheduled,for Friday, November 7, 2008., ... shares of United,American Healthcare,s common stock, Lloyd I. Miller ... The proposal for the election of directors,is more fully ...
... 4 The National Patient Safety Foundation,(NPSF) today ... forum for leading health care solutions providers to ... and,patients and their families -- all with the ... (Logo: http://www.newscom.com/cgi-bin/prnh/20080307/AQF053LOGO ), "We are excited ...
... the University of Pennsylvania School of Medicine can now ... mature B-cells in the blood stream at any one ... germs to fight infections. , "There is a steady ... for humans," says senior author Michael P. Cancro, PhD, ...
... arthritis now have many more treatment options than in ... drugs, derived by modifying substances found in humans or ... treating the symptoms. The cost of biologic DMARDs is ... cost 100 times more than a year,s supply of ...
... Pycnodysostosis, a condition from which the painter Henri de ... stature. This rare disease, surprisingly, provides a window into ... by deficiency of an enzyme known as cathepsin K ... in bone modeling and repair), leading to poor bone ...
... HOUSTON, Nov. 4 US Oncology today announced ... has,exceeded the $10 million mark in assisting more than ... Advantage in August 2006., "It was important when ... access to oral chemotherapies by easing the financial,burdens these ...
Cached Medicine News:Health News:AmerisourceBergen Joins National Patient Safety Foundation Corporate Council 2Health News:Penn scientists show how body determines optimal amount of germ-fighting B cells 2Health News:Medicaid policies vary widely for rheumatoid arthritis drugs 2Health News:Genetic disorder sheds light on enzyme's role in bone metabolism 2Health News:OncologyRx Care Advantage(TM) Specialty Pharmacy Passes $10 Million Milestone in Patient Financial Assistance 2Health News:OncologyRx Care Advantage(TM) Specialty Pharmacy Passes $10 Million Milestone in Patient Financial Assistance 3
(Date:9/19/2014)... , Sept. 19, 2014 Intarcia ... interim clinical data for its lead candidate ITCA 650 ... patients with high baseline HbA1c levels at the 50 ... the Study of Diabetes (EASD). Data from the open-label, ... levels of blood sugar in patients with poorly controlled ...
(Date:9/19/2014)... , September 19, 2014 Reductions ... for many years in people with diabetes type 2 ... long term benefits for the kidneys." Australian ... with type 2 diabetes leads to persistent reductions in ... The global study has found that, five ...
(Date:9/18/2014)... Texas , Sept. 18, 2014  Low ... FDA committee meeting in Hyattsville, Maryland ... meeting to assess the proper patient population for ... potential cardiovascular risk associated with TRT. Examining recent claims ... committee found that "available epidemiological studies do not ...
Breaking Medicine Technology:Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 2Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 3Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 4ADVANCE-ON Post-trial Observational Study: Blood Pressure Arm and Glucose Arm Results 2ADVANCE-ON Post-trial Observational Study: Blood Pressure Arm and Glucose Arm Results 3Low T Center Endorses The Joint FDA Committee Meeting on Testosterone 2
... Africa, Dec. 23, 2011 Leatt Corporation (OTC: ... a neck brace system designed to help prevent potentially devastating ... announced that it held and webcast its 2011 Annual Meeting ... was present in person or by proxy. With ...
... 23, 2011 - Stupendous success on becoming Leader ... - Company,s main focus on ,Innovation & Creativity, ... Christmas present for Mr. Veeral Desai, Managing Director, Span Diagnostics ... nation,s most coveted ,ET NOW-IndiaMART Leaders of Tomorrow Awards 2011, ...
Cached Medicine Technology:Leatt Holds 2011 Annual Meeting of Shareholders 2Span Diagnostics Ltd. Hits Bull's eye at 'ET NOW-IndiaMART Leaders of Tomorrow Awards 2011' 2Span Diagnostics Ltd. Hits Bull's eye at 'ET NOW-IndiaMART Leaders of Tomorrow Awards 2011' 3
... of emission at two different wavelengths (1064 and ... 1064 DW is able to select the delivered ... (with powers selectable among 4 and 100 W) ... 25 W). This second wavelength is very useful ...
Smartepil II is a laser particularly indicated for hair-removal where it has proved to be a valid instrument, even in the treatment of darker phototypes and telangiectasias of the face and legs....
... Tri-Active is the result of ... the combination of three different methods ... to your skin. This treatment is ... of cellulite through the combined action ...
... SmartOffice Plus is a CO2 ... to 25 W. Its functions in ... for surgery requiring extreme laser intervention ... in medical studios, it comes with ...
Medicine Products: